Citadel Advisors’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,600
Closed -$196K 13437
2025
Q3
$196K Buy
+10,600
New +$218K ﹤0.01% 11284
2025
Q2
Sell
-500
Closed -$12.3K 13877
2025
Q1
$12.3K Sell
500
-1,800
-78% -$44.5K ﹤0.01% 13451
2024
Q4
$53.3K Sell
2,300
-3,200
-58% -$80K ﹤0.01% 12321
2024
Q3
$149K Buy
5,500
+4,100
+293% +$124K ﹤0.01% 10572
2024
Q2
$40.3K Sell
1,400
-8,100
-85% -$248K ﹤0.01% 11984
2024
Q1
$277K Buy
9,500
+1,200
+14% +$33.6K ﹤0.01% 9627
2023
Q4
$270K Buy
8,300
+3,700
+80% +$107K ﹤0.01% 9364
2023
Q3
$147K Buy
4,600
+3,700
+411% +$143K ﹤0.01% 10389
2023
Q2
$39.5K Sell
900
-6,800
-88% -$314K ﹤0.01% 12079
2023
Q1
$341K Sell
7,700
-1,400
-15% -$61.9K ﹤0.01% 9117
2022
Q4
$362K Buy
+9,100
New +$379K ﹤0.01% 8919
2021
Q1
Sell
-6,800
Closed -$281K 13481
2020
Q4
$281K Sell
6,800
-8,300
-55% -$381K ﹤0.01% 9181
2020
Q3
$693K Buy
+15,100
New +$701K ﹤0.01% 6711

Other funds holding KIDS

Citadel Advisors's KIDS Position: Q1 2026 in Review

Citadel Advisors increased its OrthoPediatrics (KIDS) stake by 21% in Q1 2026, buying an estimated $573K and bringing the position to 185,393 shares worth $2.94M. The position accounts for ﹤0.01% of the portfolio, ranked #5302.

Citadel Advisors first reported a position in KIDS in Q1 2019 and has held it in 27 quarters since. The position peaked at $5.8M in Q4 2020. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.

  • Citadel Advisors held 185,393 shares of OrthoPediatrics worth $2.94M as of Q1 2026.
  • Citadel Advisors bought 32,782 OrthoPediatrics shares in Q1 2026, an estimated $573K.
  • OrthoPediatrics made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5302 holding.
  • Citadel Advisors first reported a position in OrthoPediatrics in Q1 2019 and has held it in 27 quarters since.
  • Citadel Advisors's OrthoPediatrics position peaked at $5.8M in Q4 2020.
  • 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.